Skip to content

SEARCH

Investing News
Featured
Market
Biotech
Oil & Gas
Financial
Health
MORE
- Health
- Entertainment
- Real Estate
- Cannabis
- ESG
- Financial
- Industrials
- Food & Beverage

Search

SEARCH FOR AN ARTICLE

Search

Investing News
Featured
Market
Biotech
Oil & Gas
Financial
Health
MORE
- Health
- Entertainment
- Real Estate
- Cannabis
- ESG
- Financial
- Industrials
- Food & Beverage

HomeAmgen Inc.

Amgen Inc.

Amgen Stock Skyrockets on CEO’s Obesity Drug Progress Update

Amgen Stock Skyrockets on CEO’s Obesity Drug Progress Update

May 3, 2024

Should You Buy Amgen Stock for Its 3% Yield?

Should You Buy Amgen Stock for Its 3% Yield?

April 29, 2024

LATEST NEWS

Investing News RPM’s Economic and Weather Challenges
Investing News Investment Insights on Top Stocks
Investing News Stellantis Reports 68-Year Low in Production
Investing News Top Quantum Computing Stocks to Watch
Investing News Rivian Achieves 2024 Production Goal

All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

Advertisers
Privacy Policy
Terms of Use
DMCA Policy
Disclaimer
Contact Us

SUBSCRIBE

To get email updates from Stock Street News.

I want e-mail alerts, updates, and offers and agree to the StockStreetNews privacy policy.

Market Jar Media Inc. © 2025